<DOC>
	<DOCNO>NCT02010359</DOCNO>
	<brief_summary>This study clinical trial design ass whether fish oil treatment effective prevention obesity-related fat tissue ( adipose ) inflammation . Specifically address hypothesis fish oil treatment reduce signal chemokine pathway ( fractalkine MCP-1 ) important adipose tissue recruitment activation certain white blood cell ( macrophage ) . The study double-blind placebo-controlled trial fish oil Lovaza GlaxoSmithKline ( omega-3-acid ethyl ester ; combination ethyl ester eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) ) obese non-diabetic adult , determine Lovaza decrease marker inflammation macrophage activation adipose blood understand mechanism fish oil affect inflammation .</brief_summary>
	<brief_title>Fish Oils Adipose Inflammation Reduction</brief_title>
	<detailed_description />
	<criteria>1 . Men nonpregnant/lactating woman age 25 50 . 2 . Body Mass Index ( BMI ) â‰¥30 kg/m2 3 . Participants able give write informed consent willing comply studyrelated procedure . 1 . Diabetes Mellitus ( glucose fast &gt; 126 , random &gt; 200 , Hemoglobin A1C &gt; 6.5 % , use antidiabetic agent ) 2 . Selfreported fish shellfish allergy 3 . Planned usage prescription nonprescription medication ( contraceptive pill device ) study period . 4 . Recent ( within 6 month ) use fish oil supplement self report dietary intake &gt; 3 serving fish/month 5 . Blood pressure &gt; 140/90 6 . Recent ( within 6 month ) use statin , niacin , fenofibrates 7 . Current plan pregnancy/lactation . Premenopausal woman unwilling prevent pregnancy use follow approve contraceptive strategy : diaphragm , cervical cap , condom spermicide , surgical sterility , birth control pill , DepoProvera injection , Intrauterine device , progestin implant , abstinence . 8 . History liver disease abnormal liver function test ( aspartate aminotransferase , Alanine transaminase , Alkaline Phosphatase , gammaglutamyl transpeptidase &gt; 1.5x Upper Limit normal ; bilirubin &gt; 2x upper limit normal ) Screening Visit 9 . Men unwilling limit alcohol consumption &lt; 14 alcoholic drink per week &lt; 4 alcoholic drink per occasion participate study 10 . Women unwilling limit alcohol consumption &lt; 7 alcoholic drink per week &lt; 3 alcoholic drink per occasion participate study . 11 . Hemoglobin le 11.0 g/dL 12 . Any report arrhythmia , usage antiarrhythmic therapy , abnormal screen electrocardiogram 13 . Known bleed disorder coagulopathy 14 . Any major active rheumatologic , pulmonary , hematologic dermatologic disease inflammatory condition minor active infection 15 . Selfreported history HIV positive 16 . Patients undergone organ transplant 17 . Individuals currently use tobacco product do previous 30 day 18 . Treatment aspirin , non steroidal antiinflammatories , COX2 inhibitor , steroid immunomodulatory therapy 2 week prior Screening Visit 19 . Participants unwilling eliminate omega3 fatty acid ( EPA + DHA ) supplement and/or fortify food , usual intake high omega3 fish ( tuna nonfried fish ) &gt; 3 4 serving per month assess simple screening questionnaire 20 . Recent ( within 6 month ) treatment coumarintype anticoagulant 21 . Positive urine pregnancy test result . 22 . Selfreported history injected recreational drug use . 23 . Any medical condition abnormal laboratory value judge clinically significant investigator</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>